KYMR compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

KYMRKymera Therapeutics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

KYMRKymera Therapeutics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

KYMRKymera Therapeutics, Inc.

131.73▲+2.82%· post 131.72· delayed

Mkt cap$10.9BRevenue$65MQ2 FY26Revenue$39MFY25

AMGNAmgen Inc

460.55▲+0.06%· post 460.13· delayed

After hoursNov 6 '26delayed

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

After hoursNov 6 '26delayed

KYMRKymera Therapeutics, Inc.

AMGNAmgen Inc

131.73▲+2.82%post 131.72delayed

Price

460.55▲+0.06%post 460.13delayed

$10.9B

Mkt cap

$249.0B

Q2 FY26$65M

Revenue

$10.4BQ3 FY26

FY25$39M

Revenue

$36.8BFY25

KYMR131.73▲+2.82%vsAMGN460.55▲+0.06%After hoursNov 6 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

KYMR: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only KYMR 4

GILDGilead Sciencescustomer

VERXVertex Pharmaceuticalscustomer

SNYSanoficustomer

SNYNFSanoficustomer

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customerSource: SEC EDGAR

8 more · AMGN chain ›

Price

rebased to 0%

KYMR, solidAMGN, dashed